Advances in the biology and treatment of myeloma bone disease-Reference-Cited by-同舟云学术

Advances in the biology and treatment of myeloma bone disease

Published:2001-11-01 Issue:suppl_3 Volume:58 Page:S16-S20
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Berenson James R.¹

Affiliation:

1. University of California—Los Angeles School of Medicine, and Director, Multiple Myeloma and Bone Metastasis Programs, Division of Hematology/ Oncology, Cedars Sinai Medical Center, Bev. Mod. 1, Room 100, 8700 Beverly Boulevard, Los Angeles, CA 90048

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/58/suppl_3/S16/28458539/ajhp0s16.pdf

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a method using ultra performance liquid chromatography coupled to tandem mass spectrometry for determination of zoledronic acid concentration in human bone;Journal of Pharmaceutical and Biomedical Analysis;2019-01

2. International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell Transplantation;Journal of Clinical Oncology;2014-02-20

3. Quantitation of zoledronic acid in murine bone by liquid chromatography coupled with tandem mass spectrometry;Journal of Chromatography B;2013-09

4. Matrix Metalloproteinase-9 Expression in Alveolar Extraction Sockets of Zoledronic Acid–Treated Rats;Journal of Oral and Maxillofacial Surgery;2011-11

5. Inhibition of the mevalonate pathway and activation of p38 MAP kinase are independently regulated by nitrogen-containing bisphosphonates in breast cancer cells;European Journal of Pharmacology;2007-09